Recent News & Comments About administration drug food
FDA questions Amgen drug for prostate cancer
Scientists for the Food and Drug Administration say that an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side effects.
FDA question's Amgen drug for prostate cancer
Scientists for the Food and Drug Administration say an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug failed to extend life and carried significant side effects.
FDA questions new use for Amgen drug
Amgen has asked the FDA to approve the injectable drug Xgeva as a preventive measure for men with recurring prostate cancer that is at high risk of spreading to the bone. Scientists for the Food and Drug Administration say that an Amgen Inc. drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug did not extend life and carried significant side ...
FDA staff unsure about new use for Amgen's Xgeva
WASHINGTON (Reuters) - Reviewers from Food and Drug Administration said they were not sure whether Amgen Inc's Xgeva bone drug should be also approved as a treatment to delay the spread of cancer to the bone. The FDA reviewers' concerns, raised in documents released on Monday, appeared to dim any serious hopes that an advisory panel of outside experts would recommend approval of an expanded use ...
ETView Medical, Ltd. Announced Filing of a 510(k) Pre-Marketing Notification Application with the US Food and Drug ...
ETView today announced that the company has successfully completed filing of a Pre-Marketing Notification Application ) with the US Food and Drug Administration .
MindChild Medical, Inc. Announces Filing of a 510(k) Pre-Marketing Notification Application with the US Food and Drug ...
MindChild Medical, Inc. today announced that it has successfully completed filing of a Pre-Marketing Notification Application ) with the US Food and Drug Administration for its MERIDIAN non-invasive fetal heart monitor.
Neurelis Announces FDA Allowance of IND Application for NRL-1, a Novel Intranasal Diazepam Formulation
SAN DIEGO, Feb. 6, 2012 /PRNewswire/ -- Neurelis, Inc. today announced that the United States Food and Drug Administration (FDA) has cleared an Investigational New Drug application (IND) to commence clinical ...
U.S. Food And Drug Administration Approves Pfizer’s INLYTA® (axitinib) For Patients With Previously Treated Advanced ...
Pfizer Inc. announced today that the U.S. Food and Drug Administration has approved INLYTA® , a kinase inhibitor, for the treatment of patients with advanced renal cell carcinoma after failure of one prior systemic therapy.
Hometownstations.com-WLIO- Lima, OH News Weather SportsFDA question's Amgen drug for prostate cancer
WASHINGTON (AP) - Scientists for the Food and Drug Administration say an Amgen drug slowed the spread of cancer to the bone in men with hard-to-treat prostate cancer, though the drug failed to extend life and carried significant side effects.
Brown, Kucinich Seek FDA Action to Protect Dogs From ‘Tainted’ Treats
Both U.S. Sen. Sherrod Brown and U.S. Rep. Dennis Kucinich have sent letters to the Food and Drug Administration commissioner...
 |
|
Free Diet Articles
|
